Med-Tech Innovation April 2, 2020
Lu Rahman speaks to Owen Mumford Pharmaceutical Services about the findings of its recent report scoping the near-term competitive biosimilars market in the USA and Europe, and its impact on drug delivery device design.
The available market for biosimilar manufacturers seeking to compete with original reference biologics coming off patent between late 2018 and 2023 in the USA and Europe, is considerable. However, says Owen Mumford Pharmaceutical Services, even where clinicians encourage the use of biosimilars for the patient, there remain some key considerations to overcome. This includes clinical confidence in the biosimilar; competitive pricing of drugs through greater competition; and patient confidence in the drug delivery device.
Owen Mumford Pharmaceutical Services’ study reveals the size of...
Today's Sponsors
Today's Sponsor